| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.50B | 46.63B | 50.93B | 67.44B | 59.69B | 45.28B |
| Gross Profit | 7.17B | 7.61B | 8.24B | 10.81B | 9.14B | 6.56B |
| EBITDA | 2.59B | 2.93B | 3.34B | 5.01B | 3.64B | 1.63B |
| Net Income | 1.58B | 1.79B | 2.09B | 3.31B | 2.34B | 889.41M |
Balance Sheet | ||||||
| Total Assets | 26.59B | 29.23B | 28.47B | 33.50B | 32.83B | 26.57B |
| Cash, Cash Equivalents and Short-Term Investments | 5.80B | 8.13B | 6.17B | 6.08B | 6.15B | 5.91B |
| Total Debt | 1.31B | 722.43M | 1.15B | 2.47B | 2.10B | 645.65M |
| Total Liabilities | 10.42B | 10.54B | 10.00B | 14.89B | 15.20B | 10.17B |
| Stockholders Equity | 16.18B | 18.69B | 18.47B | 18.61B | 17.63B | 16.40B |
Cash Flow | ||||||
| Free Cash Flow | 1.48B | 3.90B | 3.71B | 2.01B | -472.81M | 2.45B |
| Operating Cash Flow | 1.52B | 3.94B | 3.79B | 2.90B | 426.21M | 2.51B |
| Investing Cash Flow | -2.24B | -30.33M | 28.58M | -897.98M | -696.80M | 671.08M |
| Financing Cash Flow | -847.04M | -1.96B | -3.74B | -2.09B | 497.35M | -1.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥53.74B | 12.37 | ― | 0.91% | 5.28% | 18.38% | |
72 Outperform | ¥139.49B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
72 Outperform | €6.98T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
70 Outperform | ¥22.27B | 13.77 | ― | 6.06% | -1.22% | -7.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥2.07T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% | |
59 Neutral | ¥49.52B | 195.39 | ― | 5.01% | -32.74% | -117.06% |